Special Pathogen of Concern: Lassa Fever Outbreak in Nigeria (2026 Update)
Share this article
Nigeria is currently experiencing an ongoing Lassa fever outbreak with increasing severity, raising concerns for regional health systems and global preparedness. As of epidemiological week 12 (March 2026), the outbreak is marked by a high case fatality rate, continued geographic spread, and a growing impact on healthcare workers.
Current Situation
Between January and mid-March 2026, Nigeria has reported 637 laboratory-confirmed cases and 160 deaths, resulting in a case fatality rate (CFR) of 25.1% (Nigeria CDC, Accessed April 3, 2026, https://ncdc.gov.ng/diseases/sitreps/?cat=5&name=An+update+of+Lassa+fever+outbreak+in+Nigeria) —significantly higher than the 18.4% reported during the same period in 2025.
Cases have been identified across 22 states and 91 local government areas, with approximately 84% concentrated in five states: Bauchi, Ondo, Taraba, Benue, and Edo.
Epidemiological Trends
The outbreak disproportionately affects young adults aged 21–30 years, though cases range from ages 1 to 90.
In this outbreak, it is estimated that up to 80% of infections may be asymptomatic, which suggests that the true burden of disease may be significantly underrecognized. Asymptomatic infection complicates surveillance efforts and increases the potential for undetected transmission, particularly in household and healthcare settings.
Healthcare Worker Impact
A concerning feature of the 2026 outbreak is the continued infection of healthcare workers. As of week 12, 39 healthcare workers have been infected, including physicians, with reported deaths among clinical staff.
Healthcare-associated transmission remains a critical risk, particularly in settings where early case recognition is delayed or infection prevention and control (IPC) measures are inconsistently applied. Lassa virus spreads through direct contact with blood, tissues, secretions, or other bodily fluids, placing frontline healthcare personnel at heightened risk.
Challenges
Nigeria has activated a coordinated national response, including deployment of response teams and distribution of PPE and medical countermeasures.
Despite these efforts, several challenges continue to drive transmission and severity:
- Delayed care-seeking and late presentation, contributing to higher mortality
- High cost of treatment, limiting access to timely care
- Poor environmental sanitation in high-burden communities
- Gaps in awareness and health education
- Ongoing healthcare worker infections, indicating vulnerabilities in infection prevention and control
Implications for Healthcare Systems
This outbreak highlights persistent challenges in outbreak detection and response, particularly in healthcare settings. The combination of asymptomatic infection, ongoing transmission, and healthcare worker impact underscores the need for:
- Strong infection prevention and control practices
- Early recognition and triage of suspected cases
- Continued training and support for healthcare workers
- Reliable access to PPE and diagnostics
Why This Matters for U.S. Healthcare Workers
Lassa fever is endemic in parts of West Africa, where it causes regular seasonal outbreaks.
With increasing international travel, including major global events like the upcoming World Cup, there is a greater likelihood of travelers arriving from endemic regions. While imported cases may be rare, the potential for isolated cases in the U.S. increases with global movement.
For U.S. healthcare workers, this means:
- Maintaining a high index of suspicion for patients with compatible symptoms and relevant travel history
- Recognizing that patients may present early or with non-specific symptoms
- Understanding that transmission risk is highest in healthcare settings without proper precautions
Early identification is critical—not only for patient care, but also to prevent exposure among healthcare workers and other patients.
Transmission and Clinical Considerations
Lassa fever is caused by Lassa virus (LASV), an arenavirus endemic to West Africa. It is primarily transmitted through exposure to food or household items contaminated by urine or feces of infected rodents (Mastomys species).
Human-to-human transmission can occur through direct contact with blood, tissues, secretions, or excretions of infected individuals, particularly in healthcare settings where exposure to bodily fluids is more likely.
Because symptoms can range from mild to severe—and many infections may be asymptomatic—early recognition and strict adherence to infection prevention and control measures are essential.
NETEC Resources to Support Lassa Fever Preparedness
NETEC offers a range of Lassa fever–specific resources to help healthcare facilities and frontline personnel prepare for and safely manage suspected or confirmed cases.
Lassa Fever–Specific Guidance and Tools
NETEC’s Lassa Fever Resource Library includes clinician guides, FAQs, SBAR communication tools, and reference materials designed to support real-time decision-making during a response:
https://repository.netecweb.org/exhibits/show/lassa/lassa
These tools help teams quickly align on protocols for patient identification, isolation, and management—especially in high-risk or uncertain situations.
Training and Frontline Preparedness
Healthcare workers can access Just-in-Time training materials, clinician summaries, and educational resources to better recognize symptoms, understand transmission risks, and apply appropriate precautions:
https://repository.netecweb.org/exhibits/show/lassa/lassa
Resources such as the “Identify, Isolate, Inform” tip sheet reinforce key steps for early recognition and safe response.
Infection Prevention, PPE, and Clinical Care
NETEC provides detailed guidance on:
- Personal protective equipment (PPE) and biocontainment practices
- Waste management and environmental cleaning
- Prevention of healthcare-associated transmission
These resources are critical, as Lassa virus can spread through exposure to infectious body fluids in healthcare settings:
https://repository.netecweb.org/exhibits/show/lassa/lassa
Laboratory and Operational Resources
NETEC also offers laboratory guidance, specimen handling protocols, and shipping requirements for suspected Lassa cases, including considerations for Category A infectious substances:
https://repository.netecweb.org/items/show/1667
Additional tools include preparedness checklists and exercise templates to help facilities test and strengthen their response capabilities.
Expert Support
Organizations can also submit questions directly to NETEC experts for guidance on PPE, protocols, and operational planning during a Lassa fever event:
https://repository.netecweb.org/exhibits/show/lassa/lassa
What You Can Do Now
- Healthcare facilities: Review Lassa-specific protocols, conduct tabletop exercises, and ensure staff are familiar with PPE and isolation procedures
- Frontline healthcare workers and EMS: Refresh training on identifying and managing patients with compatible symptoms and travel history
- Administrators and planners: Use NETEC checklists and request consultation services to strengthen readiness for viral hemorrhagic fevers